ArticleHuman vaccines & immunotherapeutics2023

Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).

Kathryn Kline et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.